QUIVIVE

Quivive Pharma Inc.

Application Filed: 2018-12-12

Trademark Application Details

Mark For: QUIVIVE™ trademark registration is intended to cover the category of pharmaceutical compositions comprising a therapeutic agent and a respiratory stimulant for the amelioration of pain. [all]

Status

2021-02-07 UTC

LIVE APPLICATION Under Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	88227052
Mark Literal Elements	QUIVIVE
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2019-07-02
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Justin G. Sanders
Attorney Docket Number	RP1-005USTM

Timeline

2018-12-12	Application Filed
2019-01-04	Location: NEW APPLICATION PROCESSING
2019-01-04	Status: Live/Pending
2019-01-04	Transaction Date
2019-05-07	Published
2019-05-07	Published for Opposition
2019-07-02	Location: INTENT TO USE SECTION
2020-12-20	Status: A third request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party:	Quivive Pharma Inc.
Address	1560-1 Newbury Road Newbury Park, CALIFORNIA UNITED STATES 91320
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Drawing	JPEG	2018-12-12
TEAS RF New Application	MULTI	2018-12-12
Examiners Amendment	XML	2019-03-11
Notation to File	XML	2019-03-11
XSearch Search Summary	XML	2019-03-11
Amendment and Mail Process Complete	MULTI	2019-03-12
TRAM Snapshot of App at Pub for Oppostn	MULTI	2019-03-12
Notice of Publication	XML	2019-04-17
Notification Of Notice of Publication	XML	2019-04-17
OG Publication Confirmation	APPLICATION/XML	2019-05-07
Notice of Allowance	APPLICATION/XML	2019-07-02
Extension of Time to File SOU	XML	2019-12-19
ITU Extension Approval	APPLICATION/XML	2019-12-21
ITU Unit Action	MULTI	2019-12-21
Extension of Time to File SOU	XML	2020-07-01
ITU Extension Approval	APPLICATION/XML	2020-07-03
ITU Unit Action	MULTI	2020-07-03
Extension of Time to File SOU	XML	2020-12-20
ITU Extension Approval	APPLICATION/XML	2020-12-22
ITU Unit Action	MULTI	2020-12-22

Attorney of Record

JUSTIN G. SANDERS
ENTRALTA P.C.
2127 OLYMPIC PARKWAY, SUITE 1006 #367
CHULA VISTA, CA 91915

Good, Services, and Codes

IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical compositions comprising a therapeutic agent and a respiratory stimulant for the amelioration of pain

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
TR0010	The English translation of "QUIVIVE" in the mark is "alert".

Trademark Filing History

Description	Date	Proceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-12-22
TEAS EXTENSION RECEIVED	2020-12-20
EXTENSION 3 GRANTED	2020-12-20	98765
EXTENSION 3 FILED	2020-12-20	98765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-07-03
TEAS EXTENSION RECEIVED	2020-07-01
EXTENSION 2 GRANTED	2020-07-01	98765
EXTENSION 2 FILED	2020-07-01	98765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-12-21
TEAS EXTENSION RECEIVED	2019-12-19
EXTENSION 1 GRANTED	2019-12-19	98765
EXTENSION 1 FILED	2019-12-19	98765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2019-07-02
PUBLISHED FOR OPPOSITION	2019-05-07
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-05-07
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2019-04-17
LAW OFFICE PUBLICATION REVIEW COMPLETED	2019-04-01	73296
ASSIGNED TO LIE	2019-03-31	73296
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2019-03-11	6328
EXAMINERS AMENDMENT E-MAILED	2019-03-11	6328
EXAMINERS AMENDMENT -WRITTEN	2019-03-11	87033
EXAMINER'S AMENDMENT ENTERED	2019-03-11	88888
ASSIGNED TO EXAMINER	2019-03-11	87033
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-03-11
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2019-01-04
NEW APPLICATION ENTERED IN TRAM	2018-12-15

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
QUIVIVE 97741047 not registered Live/Pending	Kalinsky, Jake 2023-01-04
QUIVIVE 88227052 not registered Live/Pending	Quivive Pharma Inc. 2018-12-12
QUIVIVE 87265861 not registered Dead/Abandoned	Epitel, Inc. 2016-12-12
QUIVIVE 75533504 2257315 Dead/Cancelled	Gigamic, S.A. 1998-08-10
QUIVIVE 73534533 1394167 Dead/Cancelled	SPERO, LOUIS ANTHONY 1985-04-29
QUIVIVE 73534533 1394167 Dead/Cancelled	MARKISZ-SPERO, ANNE L. 1985-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.